IL-17, a pro-inflammatory cytokine primarily secreted by Th17 cells, promotes the activation of fibroblast-like synoviocytes (FLS) in RA patients and, along with IL-6, drives osteoclastogenesis. This evidence concerns the gene IL17A and rheumatoid arthritis.